Effects of lorazepam and WAY-200070 in larval zebrafish light/dark choice test

Neuropharmacology. 2015 Aug:95:226-33. doi: 10.1016/j.neuropharm.2015.03.022. Epub 2015 Apr 1.

Abstract

Zebrafish larvae spend more time in brightly illuminated area when placed in a light/dark testing environment. Here we report that the anxiolytic drugs lorazepam and diazepam increased the time larval fish spent in the dark compartment in the light/dark test. Lorazepam did not affect the visual induced optokinetic response of larval fish. Gene expression levels of c-fos and crh were significantly increased in the hypothalamus of fish larvae underwent light/dark choice behavior, whilst lorazepam treatment alleviated the increased c-fos and crh expressions. Furthermore, we found estrogen receptor β gene expression level was increased in fish larvae underwent light/dark choice. We next examined effects of estrogen receptor modulators (estradiol, BPA, PHTPP, and WAY-200070) in the light/dark test. We identified WAY-200070, a highly selective ERβ agonist significantly altered the light/dark choice behavior of zebrafish larvae. Further investigation showed WAY-200070 treatment caused a reduction of crh expression level in the hypothalamus, suggesting activation of ERβ signaling attenuate the stress response. Interestingly, WAY-200070 treatment caused marked increase of c-fos expression in the habenula of fish larvae underwent behavior test. These results suggest WAY-200070 activation of ERβ mediated signaling may regulate anxiety related behavior in zebrafish through modulation of neuronal activity in habenula.

Keywords: Anxiety; Benzodiazepines; Estrogen receptor beta; Habenula; Zebrafish.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Anxiety Agents / pharmacology*
  • Anxiety / drug therapy*
  • Anxiety / metabolism
  • Boron Compounds / pharmacology
  • Choice Behavior / drug effects
  • Choice Behavior / physiology
  • Diazepam / pharmacology
  • Estradiol / analogs & derivatives
  • Estradiol / pharmacology
  • Estrogen Receptor beta / metabolism
  • Habenula / drug effects
  • Habenula / metabolism
  • Hypothalamus / drug effects
  • Hypothalamus / metabolism
  • Larva
  • Light
  • Lorazepam / pharmacology*
  • Models, Animal
  • Neuropsychological Tests
  • Oxazoles / pharmacology*
  • Phenols / pharmacology*
  • Phenylalanine / analogs & derivatives
  • Phenylalanine / pharmacology
  • Proto-Oncogene Proteins c-fos / metabolism
  • Pyrazoles / pharmacology
  • Pyrimidines / pharmacology
  • Visual Perception / drug effects
  • Visual Perception / physiology
  • Zebrafish
  • Zebrafish Proteins / metabolism

Substances

  • 4-(2-phenyl-5,7-bis(trifluoromethyl)pyrazolo(1,5-a)pyrimidin-3-yl)phenol
  • 4-dihydroxyborylphenylalanine
  • Anti-Anxiety Agents
  • Boron Compounds
  • Estrogen Receptor beta
  • Oxazoles
  • Phenols
  • Proto-Oncogene Proteins c-fos
  • Pyrazoles
  • Pyrimidines
  • WAY 200070
  • Zebrafish Proteins
  • estradiol 3-benzoate
  • Phenylalanine
  • Estradiol
  • Lorazepam
  • Diazepam